Anbenitamab plus HB1801 for HER2-Positive Advanced Breast Cancer. (nejm.org)

Authors: Wang J … Xu B Journal: New England Journal of Medicine Published: 2026-10-24 DOI: https://doi.org/10.1056/NEJMoa2610345